Use of the zebrafish larvae as a model to study cigarette smoke condensate toxicity

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Ellis, Lee D ^a   Soo, Evelyn C ^b   Achenbach, John C ^a   Morash, Michael G ^a   Soanes, Kelly H ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE CONDENSATE; PASSIVE SMOKING; ZEBRAFISH PROTEIN;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANADA; CARDIOTOXICITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEVELOPMENTAL TOXICITY; EMBRYO; HIGH THROUGHPUT SCREENING; IN VIVO STUDY; LARVA; NEUROTOXICITY; NONHUMAN; SMOKING; ZEBRA FISH; ADVERSE EFFECTS; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MUTAGEN TESTING; PASSIVE SMOKING; PATHOPHYSIOLOGY; PROCEDURES; TOXICITY AND INTOXICATION; TOXICOGENETICS;

DANIO RERIO; MAMMALIA; NICOTIANA TABACUM;

ANIMALS; CANADA; CARDIOTOXICITY; DISEASE MODELS, ANIMAL; HUMANS; LARVA; MUTAGENICITY TESTS; NEUROTOXICITY SYNDROMES; SMOKING; TOBACCO SMOKE POLLUTION; TOXICOGENETICS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84919498928     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115305     Document Type: Article

References (51)

1. US Department of Health and Human Services Centers for Disease Control and Prevention (2004) The health consequences of smoking. A Report of the Surgeon General. Atlanta: National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Available from: Supt of Docs, US GPO.
2. World Health Organization (2011) WHO report on the global tobacco epidemic, 2011: Warning about the dangers of tobacco. Geneva: WHO Press.
3. Baliunas D, Patra J, Rehm J, Popova S, Kaiserman MJ et al. (2007) Smoking-attributable mortality and expected years of life lost in Canada 2002: Conclusions for prevention and policy. Chronic Dis Can 27: 154-162.
4. Rehm J, Ballunas D, Brochu S, Fischer B, Gnam W et al. (2006) The costs of substances abuse in Canada 2002. Ottawa: Canadian Centre on Substance Abuse.
5. Health Canada (2011) Canadian Tobacco Monitoring Survey (CTUMS) 2011. Available: http://www.hcsc.gc.ca/hc-ps/tobac-tabac/research-recherche/stat/ctums-esutc-2011-eng.php. Accessed 2013 November 4.
6. Physicians for a Smoke-free Canada (1999) The Engineering of Canadian Cigarettes. Available: http://www.smoke-free.ca/pdf-1/Background-design.pdf. 2013 November 4.
7. Lesser C, von Borstel RW (2003) Cigarette filter containing dry water and a porphyrin. United States Patent 6,530,377, March 11 2003, United States Patent and Trademark Office website. Available: http://pdfpiw.uspto.gov/.piw?Docid=06530377&homeurl=http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1%26Sect2=HITOFF%26d=PALL%26p=1%26u=%252Fnetahtml%252FPTO%252Fsrchnum.htm%26r=1%26f=G%26l=50%26s1=6,530,377.PN%26OS=PN/6,530,377%26RS=PN/6,530,377&PageNum=&Rtype=&SectionNum-&idkey=NONE&Input=View+first+page%20. Accessed 28 October 2013.
8. Seguin BP, Bouffard MC, Soo EC (2012) Do Canadian MicroBlueTM filter cigarettes have reduced toxicant levels. SRNT's 18th Annual Meeting; 13-16 March 2012, Society for Research on Nicotine and Tobacco, Houston, TX, USA.
9. Siu M, Mladjenovic N, Soo E (2013) The analysis of mainstream smoke emissions of Canadian 'super slim' cigarettes. Tob Control 22: e10.
10. (2000) Tobacco Reporting Regulations. Minister of Justice. Ottawa, Ontario, Canada. SOR/2000-273. Available: http://laws-lois.justice.gc.ca/eng/regulations/SOR-2000-273/. Accessed 2013 October 19.
11. Barros TP, Alderton WK, Reynolds HM, Roach AG, Berghmans S (2008) Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br J Pharmacol 154: 1400-1413.
12. Berghmans S, Butler P, Goldsmith P, Waldron G, Gardner I et al. (2008) Zebrafish based assays for the assessment of cardiac, visual and gut function-potential safety screens for early drug discovery. J Pharmacol Toxicol Methods 58: 59-68.
13. Fleming A, Alderton WK (2013) Zebrafish in pharmaceutical industry research: finding the best fit. Drug Discovery Today: Disease Models 10: e-43-e50.
14. Fan CY, Cowden J, Simmons SO, Padilla S, Ramabhadran R (2010) Gene expression changes in developing zebrafish as potential markers for rapid developmental neurotoxicity screening. Neurotoxicol Teratol 32: 91-98.
15. Padilla S, Corum D, Padnos B, Hunter DL, Beam A et al. (2012) Zebrafish developmental screening of the ToxCast Phase I chemical library. Reprod Toxicol 33: 174-187.
16. Sipes NS, Padilla S, Knudsen TB (2011) Zebrafish: as an integrative model for twenty-first century toxicity testing. Birth Defects Res C Embryo Today 93: 256-267.
17. Peterson RT, Macrae CA (2012) Systematic approaches to toxicology in the zebrafish. Annu Rev Pharmacol Toxicol 52: 433-553.
18. US Department of Health and Human Services (2010) How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the Surgeon General. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
19. Bailey J, Oliveri A, Levin ED (2013) Zebrafish model systems for developmental neurobehavioral toxicology. Birth Defects Res C Embryo Today 99: 14-23.
20. Svoboda KR, Vijayaraghavan S, Tanguay RL (2002) Nicotinic receptors mediate changes in spinal motoneuron development and axonal pathfinding in embryonic zebrafish exposed to nicotine. J Neurosci. 22: 10731-10741.
21. Muth-Kohne E, Wichmann A, Delov V, Fenske M (2012) The classification of motor neuron defects in the zebrafish embryo toxicity test (ZFET) as an animal alternative approach to assess developmental neurotoxicity. Neurotoxicol Teratol 34: 413-424.
22. MacPhail RC, Brooks J, Hunter DL, Padnos B, Irons TD et al. (2009) Locomotion in larval zebrafish: Influence of time of day, lighting and ethanol. Neurotoxicology 30: 52-58.
23. Irons TD, MacPhail RC, Hunger DL, Padilla S (2010) Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol 32: 84-90.
24. Staddon JE, MacPhail RC, Padilla S (2010) The dynamics of successive induction in larval zebrafish. J Exp Anal Behav 94: 261-266.
25. Zellner D, Padnos B, Hunter DL, MacPhail RC, Padilla S (2011) Rearing conditions differentially affect the locomotor behavior of larval zebrafish, but not their response to valproate-induced developmental neurotoxicity. Neurotoxicol Teratol 33: 674-679.
26. Cowden J, Padnos B, Hunter D, MacPhail R, Jensen K et al. (2012) Developmental exposure to valproate and ethanol alters locomotor activity and retino-tectal projection area in zebrafish embryos. Reprod Toxicol 33: 165-173.
27. International Organization for Standardization (2004) ISO 10185:2004 Tobacco and tobacco products - vocabulary, Geneva: International Organization for Standardization. Available from: http://www.iso.org/iso/catalogue-detail.htm?csnumber=31190.
28. Centers for Disease Control and Prevention (2011) Tobacco Brand preferences. Available: http://www.cdc.gov/tobacco/data-statistics/fact-sheets/tobacco-industry/brand-preference/index.htm, Accessed 2013 November 4.
29. International Organization for Standardization (1999) ISO 3402:1999 Tobacco and tobacco products - Atmosphere for conditioning and testing, Geneva: International Organization for Standardization. Available from: http://www.iso.org/iso/catalogue-detail.htm?csnumber=28324.
30. International Organization for Standardization (2012) ISO 3308:2012 Routine analytical cigarettesmoking machine - Definitions and standard conditions, Geneva: International Organization for Standardization. Available from: http://www.iso.org/iso/home/store/catalogue-tc/catalogue-detail. htm?csnumber560404.
31. Health Canada (1991) Health Canada Test Method T-115 - Determination of 'tar', water, nicotine and carbon monoxide in mainstream smoke, Ottawa: Health Canada. Available from: Controlled Substances and Tobacco Directorate, Health Canada.
32. Westerfield M (1995) The zebrafish book: A guide for Laboratory us of Zebrafish (Danio rerio). Eugene: University of Oregon Press.
33. Dukovcic SR, Hutchison JR, Trempy JE (2010) Conservation of the chromatophore pigment response. J Appl Toxicol 30: 574-581.
34. Abbott LC, Winzer-Serhan UH (2012) Smoking during pregnancy: lessons learned from epidemiological studies and experimental studies using animal models. Crit Rev Toxicol 42: 279-303.
35. Incardona JP, Day HL, Collier TK, Scholz NL (2006) Developmental toxicity of 4-ring polycyclic aromatic hydrocarbons in zebrafish is differentially dependent on AH receptor isoforms and hepatic cytochrome P4501A metabolism. Toxicol Appl Pharmacol 217: 308-321.
36. Milan DJ, Jones IL, Elinor PT, MacRae CA (2006) In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am J Physiol Heart Circ Physiol 291: H269-H273.
37. Pruvot B, Quiroz Y, Voncken A, Jeanray N, Piot A et al. (2012) A panel of biological tests reveals developmental effects of pharmaceutical pollutants on late stage zebrafish embryos. Reprod Toxicol 34: 568-583.
38. Dhillon SS, Dóró E, Magyary I, Egginton S, Sík A et al. (2013) Optimisation of embryonic and larval ECG measurement in zebrafish for quantifying the effect of QT prolonging drugs. PLoS One 8: e60552.
39. McGee SP, Konstantinov A, Stapleton HM, Volz DC (2013) Aryl phosphate esters within a major PentaBDE replacement product induce cardiotoxicity in developing zebrafish embryos: potential role of the aryl hydrocarbon receptor. Toxicol Sci 133: 144-1456.
40. Park MJ, Lee KR, Shin DS, Chun HS, Kim CH et al. (2013) Predicted drug-induced bradycardia related cardio toxicity using a zebrafish in vivo model is highly correlated with results from in vitro tests. Toxicol Lett 216: 9-15.
41. Haag HB, Larson PS, Finnegan JK (1959) Effect of filtration on the chemical and irritating properties of cigarette smoke. AMA Arch Otolaryngol 69: 261-265.
42. Guo X, Verkler TL, Chen Y, Richter PA, Polzin GM et al. (2011) Mutagenicity of 11 cigarette smoke condensates in two versions of the mouse lymphoma assay. Mutagenesis 26: 273-281.
43. Counts ME, Morton MJ, Laffoon SW, Cox RH, Lipowicz PJ (2005) Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul Toxicol Pharmacol 41: 185-227.
44. Antal S, Szende B, Lengyel J, Hidvéqi EJ (2009) Joint effects of cigarette smoking and irradiation in pregnant mice and their offspring. In Vivo 23: 267-272.
45. Kuo WH, Chen JH, Lin HH, Chen BC, Hsu JD et al. (2005) Induction of apoptosis in the lung tissue from rats exposed to cigarette smoke involves p38/JNK MAPK pathway. Chem Biol Interact 155: 31-42.
46. Spira A, Beane J, Shah V, Liu G, Schembri F et al. (2004) Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci U S A 101: 10143-10148.
47. Sridhar S, Schembri F, Zeskind J, Shah V, Gustafson AM et al. (2008) Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genomics 9: 259.
48. Oates AC, Pratt SJ, Vail B, Yan YI, Ho RK et al. (2001) The zebrafish klf gene family. Blood 98: 1792-1801.
49. Nuez B, Michalovich D, Bygrave A, Ploemacher R, Grosveld F (1995) Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375: 316-318.
50. Perkins AC, Gaensler KM, Orkin SH (1996) Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc Natl Acad Sci U S A 93: 12267-12271.
51. Kuo CT, Veselits ML, Leiden JM (1997) LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science 277: 1986-1990.